C1orf43 Inhibitors
C1orf43 inhibitors encompass a range of chemical compounds that exert their influence through various epigenetic and transcriptional mechanisms, ultimately leading to the suppression of C1orf43's functional activity. Trichostatin A and MS-275, both histone deacetylase inhibitors, promote a relaxed chromatin state, which can counteract any gene repression C1orf43 might facilitate, thereby diminishing its role. Similarly, 5-Azacytidine and RG 108 target the DNA methylation machinery, potentially disrupting C1orf43's interaction with methylated DNA regions, assuming it plays a role in maintaining a repressive chromatin environment. Mithramycin A, Chloroquine, and Actinomycin D interfere with DNA-protein interactions and transcriptional processes, which could inhibit C1orf43 if it relies on such interactions to exert its function. Compounds like Alsterpaullone and Triptolide inhibit transcriptional events by targeting kinases and other transcriptional regulators, which could indirectly reduce C1orf43's activity if it modulates gene expression.
The action of C1orf43 inhibitors extends to the modulation of specific transcription factors and chromatin modifiers, where compounds such as I-CBP112 and JQ1 play significant roles. By inhibiting the CREBBP/EP300 and BET bromodomains, respectively, these inhibitors could disrupt the acetylation-dependent recruitment of transcriptional machinery, possibly hindering the regulatory functions of C1orf43. Alpha-amanitin's inhibition of RNA polymerase II could lead to a broad reduction in mRNA synthesis, indirectly diminishing the potential regulatory roles of C1orf43 in gene expression. Collectively, these compounds offer a diverse array of molecular interventions that could suppress the functional activity of C1orf43 by targeting the intricate network of epigenetic regulation and transcriptional control in which it may be involved.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. By increasing histone acetylation, it promotes a more open chromatin structure and thus enhances transcription. This could diminish the role of C1orf43 if it's involved in gene repression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine incorporates into DNA and RNA, inhibiting DNA methyltransferases. This leads to hypomethylation of DNA and can disrupt the function of C1orf43 if it interacts with methylated DNA regions for gene repression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, preventing the binding of transcription factors and other DNA-associated proteins, potentially diminishing C1orf43's ability to modulate gene expression if it interacts with similar regions. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine intercalates into DNA, which can disrupt DNA-protein interactions. If C1orf43 functions by interacting with DNA, chloroquine could inhibit its activity by preventing such interaction. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone is a cyclin-dependent kinase inhibitor. If C1orf43's function is regulated by CDK-mediated phosphorylation, alsterpaullone might diminish its activity by blocking this modification. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG 108 is a DNA methyltransferase inhibitor, preventing DNA methylation. This could lead to altered gene expression profiles and potentially inhibit C1orf43 if its function is dependent on the methylation status of genes. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Alpha-amanitin inhibits RNA polymerase II, thereby reducing mRNA synthesis. If C1orf43 is involved in gene expression, this reduction in transcription could indirectly diminish its function. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is a diterpene triepoxide that inhibits transcription by affecting multiple factors, potentially diminishing the functional activity of C1orf43 by reducing the transcription of genes it may regulate. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates DNA and inhibits RNA polymerase, which can reduce gene expression. This may indirectly inhibit C1orf43 activity by decreasing the expression of genes it controls. | ||||||
I-CBP112 | 1640282-31-0 | sc-507494 | 25 mg | $400.00 | ||
I-CBP112 is a CREBBP/EP300 bromodomain inhibitor. If C1orf43 is involved in acetylation-dependent transcriptional processes, inhibiting these bromodomains could diminish C1orf43 activity. | ||||||